In persons at risk for poor vaccination response or COVID-19 exposure, tixagevimab + cilgavimab reduced COVID-19. Aisenberg GM. Ann Intern Med 2022 Aug 2. doi: 10.7326/J22-0056.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Aisenberg GM. In persons at risk for poor vaccination response or COVID-19 exposure, tixagevimab + cilgavimab reduced COVID-19. Ann Intern Med 2022 Aug 2. doi: 10.7326/J22-0056.
PMID: 35914259